Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Microbial metabolite inhibits ICAM-1/LFA-1-mediated cell adhesion

March 8, 1999

Cyclooxygenase-inhibitory indoles under study at Pfizer

March 8, 1999

Cytokine production inhibitors prepared and tested at Ortho-McNeil

March 4, 1999

Medarex joins forces with Danish investors to develop human antibody therapeutics

March 4, 1999

Cysteine protease-inhibitory peptides disclosed by Takeda

March 2, 1999

New MMP and/or TNF production inhibitors developed by Pfizer research group

March 2, 1999

Clinical study of La Jolla's lupus drug expanded to Europe and Canada

March 2, 1999

Zimmer launches Orthovisc in Europe; prepares to begin North American trials

Feb. 26, 1999

Rofecoxib up for advisory committee review this spring

Feb. 26, 1999

Clinically effective antiarthritic drug offered for licensing by KS Biomedix

Feb. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.